NP Life Sciences Health Industry Group Past Earnings Performance
Past criteria checks 0/6
NP Life Sciences Health Industry Group has been growing earnings at an average annual rate of 63.8%, while the Consumer Services industry saw earnings growing at 20.7% annually. Revenues have been growing at an average rate of 92.2% per year.
Key information
63.8%
Earnings growth rate
65.4%
EPS growth rate
Consumer Services Industry Growth | 20.3% |
Revenue growth rate | 92.2% |
Return on equity | -17.9% |
Net Margin | -1.8% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How NP Life Sciences Health Industry Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 0 | 0 | 0 | 0 |
30 Sep 23 | 0 | 0 | 0 | 0 |
30 Jun 23 | 0 | 0 | 0 | 0 |
31 Mar 23 | 0 | 0 | 0 | 0 |
31 Dec 22 | 0 | 0 | 0 | 0 |
30 Sep 22 | 0 | 0 | 0 | 0 |
30 Jun 22 | 0 | 0 | 0 | 0 |
31 Mar 22 | 0 | 0 | 0 | 0 |
31 Dec 21 | 0 | 0 | 0 | 0 |
30 Sep 21 | 0 | 0 | 0 | 0 |
30 Jun 21 | 0 | 0 | 0 | 0 |
31 Mar 21 | 0 | 0 | 0 | 0 |
31 Dec 20 | 0 | 0 | 0 | 0 |
30 Sep 20 | 0 | 0 | 0 | 0 |
30 Jun 20 | 0 | 0 | 0 | 0 |
31 Mar 20 | 0 | 0 | 0 | 0 |
31 Dec 19 | 0 | 0 | 0 | 0 |
Quality Earnings: NPLS is currently unprofitable.
Growing Profit Margin: NPLS is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NPLS is unprofitable, but has reduced losses over the past 5 years at a rate of 63.8% per year.
Accelerating Growth: Unable to compare NPLS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NPLS is unprofitable, making it difficult to compare its past year earnings growth to the Consumer Services industry (36.8%).
Return on Equity
High ROE: NPLS has a negative Return on Equity (-17.92%), as it is currently unprofitable.